Recursion Pharma is combining high-throughput experimental biology, bioinformatics, and machine learning to rapidly identify new indications for many known drugs and shelved assets.
Recursion Pharma is a Salt Lake City-based drug discovery company founded in 2013 based on technology developed at the University of Utah. Recursion uses a novel drug screening platform to efficiently reposition known drugs and shelved pharmaceutical assets to treat rare genetic diseases and other conditions.
-
Industry
-
Milestones
- Lux investment: 2016
-
Founders
- Chris Gibson, PhD
- Blake Borgeson, PhD
- Dean Li, PhD
LUX Partners
-
Latest Tweets
- Our President & COO @TinaMarrLarson is nominated for @UtahBusiness CXO of the Year. Tina leads our day-to-day opera… https://t.co/5Qj8qzfvk2
- We're proud to be a finalist for the @Xconomy "Digital Tech Trailblazer" award today alongside other incredibly inn… https://t.co/QioTnP494x
- Join us virtually for the Fifth Annual @CytoData Meeting on Oct. 21-22. Session 1: Immunology and COVID-19 Session… https://t.co/rpGyQT5XTn